Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Changmao Biochemical Engineering Co. Ltd. Class H ( (HK:0954) ) just unveiled an update.
Changmao Biochemical Engineering Co. Ltd. reported its annual results for the year ended December 31, 2024, revealing a decrease in revenue to RMB 584,794,000 from RMB 637,078,000 in 2023. The company also reported a reduced loss attributable to shareholders, amounting to RMB 68,243,000 compared to RMB 86,057,000 the previous year. Despite the reduced losses, the board has decided not to recommend the payment of a final dividend for the year. This financial performance reflects ongoing challenges in the company’s operations, impacting its market positioning and stakeholder expectations.
More about Changmao Biochemical Engineering Co. Ltd. Class H
Changmao Biochemical Engineering Co. Ltd. is a joint stock limited company incorporated in the People’s Republic of China. The company operates in the biochemical engineering industry, focusing on the production and sale of biochemical products.
YTD Price Performance: -6.00%
Technical Sentiment Signal: Buy
Current Market Cap: €26.19M
For a thorough assessment of 0954 stock, go to TipRanks’ Stock Analysis page.